id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-3517	Du, Yu; Qi, Zhonghui ; Liang , Xianbin ; Dai, Jie ; Wei , Xiaoting ; Bai , Xue ; Mao, Lili ; Chi , Zhihong ; Cui, Chuanliang ; Lian, Bin ; Tang , Bixia ; Wang , Xuan ; Chen , Yu ; Guo , Jun ; Si, Lu	Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study 	2024	8	.pdf	application/pdf	4146	263	58	The combination of PD-1 and cytotoxic T lymphocyte-associated antigen-4 blockade have added benefit compared with monotherapy in adult patients; however, the combination of ipilimumab/nivolumab does not seem to exert synergistic effects in pediatric patients. Whether the efficacy and safety profile of adjuvant pem- brolizumab treatment are the same in pediatric patients as in adult patients remains unclear.	cache/dpc-3517.pdf	txt/dpc-3517.txt